Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Jul 12, 2021 8:00 am EDT

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

Jul 8, 2021 4:05 pm EDT

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

Jun 22, 2021 8:00 am EDT

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

Jun 22, 2021 7:39 am EDT

BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

Jun 21, 2021 8:03 am EDT

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

Jun 17, 2021 7:00 am EDT

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

May 27, 2021 8:30 am EDT

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

May 24, 2021 7:30 am EDT

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

May 7, 2021 1:33 pm EDT

OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

Apr 28, 2021 4:05 pm EDT

OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results